Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM)Act; Ongoing discussions surrounding next steps for protecting and promoting incentives for the development of resistant pathogens including breakpoints, andtibiotic resistance, reimbursement issues for antibiotics, President's Council of Advisors on Science and Technology (PCSAT)
HCR - Health Issues
34 - Health & Human Services, Dept of (HHS)
CUBIST PHARMACEUTICALS, INC.
65 Hayden Avenue, Lexington, MA, 02421, US
MARK THOMAS BATTAGLINI